ABSTRACT Pre-mRNA splicing in yeast and higher eukaryotes proceeds by similar pathways, in which a probable splicing intermediate and the excised intron are in a lariat configuration. To compare the pre-mRNA splicing mechanisms in yeast and higher eukaryotes, we have analyzed the RNA products resulting from in vitro processing of a yeast intron-containing pre-mRNA in HeLa cell and yeast extracts. In yeast, the RNA branch (2'-5' phosphodiester bond) of the RNA lariat forms at the third adenosine of the TACTAAC box in vivo and in vitro. In contrast, in the HeLa cell extract, the yeast pre-mRNA is accurately spliced, but the RNA lariats contain RNA branches located significantly closer to the 3' splice site than the TACTAAC box. In yeast, mutant preniRNAs that lack the TACTAAC box are not spliced in vivo or in vitro. However, these same mutant pre-mRNAs are accurately spliced in the HeLa cell extract. Therefore, although pre-mRNA splicing in yeast and higher eukaryotes proceeds by the same basic pathway, there are substantial differences in the specificity of the biochemical components that mediate the formation of the RNA processing products.
branches form at adenosine residues, surrounded by variable sequences that bear weak sequence homologies to one another and to the TACTAAC box (3, 5, (10) (11) (12) (13) . Significantly, in higher eukaryotes, the adenosine residues at which RNA branches form are located within a narrow distance, 18-37 nucleotides upstream from the 3' end of the intron (3, 4, 11, 12) . Second, the yeast 5' splice junction is also highly conserved [almost always GTATGT (1, 2, 8) ], while mammalian 5' splice junctions are significantly more variable (14) . Third, mammalian pre-mRNAs are spliced improperly, inefficiently, or not at all when introduced into yeast (15, 16) .
To further investigate the differences between mammalian and yeast pre-mRNA splicing, we have analyzed the in vitro processing of a yeast pre-RNA substrate in a HeLa cell nuclear extract. Although the yeast pre-mRNA substrate is accurately spliced, branch point selection is different in HeLa cells as compared to yeast. The results support the notion that, while the two systems share the same basic splicing pathway, the specificity ofthe splicing factors in yeast differs substantially from those in HeLa cells.
The primary transcripts (pre-mRNAs) of most structural genes in higher eukaryotes contain intervening sequences (IVS) (introns) that are removed by splicing. Although most genes in yeast do not contain introns, a number of introncontaining genes, many of which encode ribosomal proteins (1, 2) , have been identified and characterized. Pre-mRNA splicing in both yeast and in higher eukaryotes proceeds by the same basic pathway that can be divided into two stages. In the first stage, the pre-RNA is cleaved at the 5' splice site to generate two splicing intermediates, the first exon RNA species and an RNA species composed of the intron (IVS) and second exon (IVS-exon 2 RNA species). In the second stage, cleavage at the 3' splice site and ligation of the exons occurs, resulting in the excision of the intact intron. The IVS-exon 2 splicing intermediate and the excised IVS are in the form of a lariat in which the 5' end of the intron is joined to an adenosine residue near the 3' end ofthe intron by a 2'-5' phosphodiester bond (3) (4) (5) (6) (7) .
Although the splicing pathway in yeast and higher eukaryotes is similar, several features of pre-mRNA splicing in the two systems suggest that there are significant differences. First, all known yeast pre-mRNA introns contain a conserved sequence element located 20-60 nucleotides upstream from the 3' splice site, referred to as the TACTAAC box. Mutagenesis studies indicate that the TACTAAC box is in fact essential for splicing in yeast (2, 8, 9) . More recently, it has been shown that the RNA branch forms at the third adenosine of the TACTAAC box during pre-mRNA splicing in yeast (6, 7) . In 1 of the SP6/rp5lAA2 pre-mRNA. The second RNA species has a decreased electrophoretic mobility (=560 nt) compared to the pre-mRNA on a 5% denaturing gel (see also Fig. 4 ). This result strongly suggests that this RNA species is the IVS-exon 2 splicing intermediate, which is in a lariat configuration. The third RNA species has the expected electrophoretic mobility of accurately spliced RNA (exon 1-exon 2; 397 nt) and accumulates during the subsequent time course. The fourth RNA species has an electrophoretic mobility of 155 nt and displays parallel kinetics to accurately spliced RNA; this RNA corresponds to the intact excised 137-nt IVS in a lariat configuration.
To confirm that the SP6/rp5lAA2 pre-mRNA was in fact accurately spliced in the HeLa cell nuclear extract, the 397-nt RNA processing product (Fig. LA) was purified and its sequence was determined by primer extension. The sequence of the 397-nt RNA product across the splice junction unambiguously demonstrates the accurate ligation of exon 2 to exon 1 (Fig. 1B) . Although the electrophoretic mobilities of the spliced RNA products present at 2 and 4 hr differ slightly (Fig. LA) , the primer extension products of these RNA species are identical (data not shown). Thus, the smaller size of the spliced RNA product at later times is most likely due to removal of sequences at the 3' end of the RNA by a 3' exonuclease activity in the extract (21 Fig. lA . We conclude that a yeast pre-mRNA can be accurately spliced in a HeLa cell nuclear extract, generating RNA processing products that are analogous to those produced from a higher eukaryotic pre-mRNA substrate (3, 4) .
Mapping the Position of the RNA Branch Generated in a HeLa Cell Nuclear Extract. To map the branch point of the SP6/rp5iAA2 pre-mRNA in the HeLa cell extract, the 32P-labeled adenosine (32P-adenosine)-labeled excised IVS lariat RNA species was purified and digested with RNase T1 either with or without prior enzymatic debranching, which specifically hydrolyzes the 2'-5' phosphodiester bond at the branched adenosine residue (21) . RNase T1 fragments that contain a branched nucleotide will be linked by a 2'-5' phosphodiester bond to pGp, which originates from the 5' end of IVS (3, 10) . After enzymatic debranching, the RNase T1 fragment that originally contained the RNA branch now lacks pGp (21) and, therefore, its electrophoretic mobility will be altered compared to the same fragment derived from the intact IVS (11, 12) . The only RNase T1 fragment that displays an altered electrophoretic mobility after enzymatic debranching is a unique 22-mer, which is located 25-46 nt upstream from the 3' splice site and does not contain the TACTAAC box ( Fig. 2A) .
To map the position of the RNA branch within the 22-nt RNase T1 fragment, RNase A secondary digestion analysis was performed. The modified 22-nt fragment and its enzymatically debranched linear counterpart were purified and digested with RNase A, and the products were fractionated by two-dimensional thin-layer chromatography (3, 22) . The excised 32P-adenosine-labeled IVS was digested with RNase T1, and the digestion products were fractionated on a denaturing 25% polyacrylamide gel. The modified 22-nt RNase T1 fragment (IVS 22-mer) was purified, digested with RNase A, and the products were fractionated by two-dimensional thin-layer chromatography (3, 22) . Purified 32P-adenosine-labeled or 32P-cytidine-labeled IVS RNA species were digested with nuclease P1 or T2, and the products were fractionated by one-dimensional thin-layer chromatography (3). As a control, a 32P-adenosine-labeled or 32P-cytidine-labeled pre-mRNA was analyzed in parallel. In the nuclease P1 digestion analyses, the positions of 5'-AMP and 5'-CMP are indicated. The arrow points to the position of a nuclease Pi-resistant component. In the nuclease T2 digestion analyses, the arrow indicates the nuclease T2-resistant component.
RNase A digestion of the unmodified 32P-adenosine-labeled 22-nt RNase T1 fragment yields four products: Up, Cp, ApCp, and ApApApCp (Fig. 2B) . When the RNase A digestion products of the modified RNase Ti fragment are similarly fractionated, the spot corresponding to ApApApCp is absent and is replaced by a new 32P-adenosine-labeled product that migrates near the origin (X). These data indicate that the branched nucleotide occurs 36-39 nt from the 3' end of the intron, within the RNase A fragment ApApApCp.
To determine the position of the branched nucleotide(s) within the RNase A fragment ApApApCp, the 32P-labeled purified IVS was subjected to nuclease P1 and T2 digestion analysis. The 2'-5' phosphodiester bond of the RNA branch renders the 3'-5' phosphodiester bond of the branched nucleotide resistant to digestion by nucleases P1 and T2 (3, 23) . The position and composition of the branched structure can be deduced by performing nuclease P1 and T2 digestions of RNAs separately labeled with one of the four ribonucleoside triphosphates (3, (10) (11) (12) . Digestion of the purified rpSiAA2 32P-cytidine-labeled IVS with nuclease P1 or nuclease T2 produces 32P-labeled nuclease-resistant components (Fig. 2C) . These results indicate that an RNA branch forms at the third adenosine residue of the RNase A fragment ApApApCp, which renders the adenosine-(3'-5')-cytosine phosphodiester bond resistant to nuclease digestion. As expected for an RNA branch at this position, the 32P_ adenosine-labeled IVS also gives rise to a detectable nuclease Pl-resistant component. However, a nuclease-resistant component is also detectable after digestion of the 32P-adenosinelabeled IVS with nuclease T2 (Fig. 2C) , indicating that some IVS RNA molecules contain a branched nucleotide at either the first or second adenosine of the RNase A fragment ApApApCp, which renders an adenosine-(3'-5')-adenosine phosphodiester bond resistant to nuclease T2 digestion. These combined data indicate that, in the HeLa cell nuclear extract, the RNA branch forms at a minimum of two adenosine residues, one 37 nt, and the other 38 and/or 39 nt upstream from the 3' splice site in the yeast rp5lAA2 RNA.
To confirm these results, the IVS-exon 2 RNA species generated in the HeLa cell extract was purified and analyzed by primer extension using a 32P-end-labeled synthetic oligonucleotide complementary to exon 2. RNA lariats give rise to a discrete primer extension product due to blockage of reverse transcriptase by the RNA branch (3, 6, 19) . Primer extension of the purified SP6/rp5iAA2 IVS-exon 2 RNA lariat produces 65-and 66-nt 32P-labeled cDNAs (Fig. 3, lane  3) , which are not detectable after enzymatic debranching of the IVS-exon 2 RNA species (data not shown). Assuming that reverse transcriptase stops precisely at the base preceding the RNA branch (6) , these data map the RNA branch to adenosine residues located 37 and 38 nt upstream from the 3' splice site, consistent with the results of the nuclease digestion analyses described above.
To preclude the possibility that branch point selection in the HeLa cell nuclear extract is an artifact of in vitro processing, the same SP6/rp5lAA2 pre-mRNA was processed in splicing extracts prepared from yeast cells (24) . Primer extension of the RNA processing products generated RNA lariats generated in HeLa cell and yeast extracts. Primer extension with reverse transcriptase was carried out with the RB1 oligonucleotide primer complementary to a sequence in exon 2 (9, 18) . Lanes: 1, in vivo RNA from a yeast strain transformed with the rp5lAA2 gene; 2, purified IVS-exon 2 RNA lariat from an in vitro processing reaction in a yeast whole-cell extract (24) ; A, G, C, and T, sequence ladder obtained by addition of the corresponding dideoxynucleotides to primer extension reactions using SP6/ rp5lAA2 pre-mRNA; 3, purified IVS-exon 2 RNA lariat from in vitro processing of the SP6/rp5lAA2 pre-mRNA in a HeLa cell nuclear extract. The positions of the 87-nt and 65-and 66-nt primer extension products are indicated on the left and right, respectively. The sequences (mRNA strand) at which the primer extension stops occur are shown on the right.
in the yeast extract gives rise to a single 87-nt 32P-labeled cDNA (Fig. 3, lane 2) , indicating that the RNA branch is at the last adenosine residue of the authentic TACTAAC box, 59 nt upstream from the 3' splice junction. The same 87-nt 32P-labeled cDNA product is generated by primer extension of in vivo RNA from a yeast strain transformed with the rpSlAA2 gene (lane 1). We conclude that in yeast the TACTAAC box of the yeast rp5lA gene functions as the branch point sequence in vivo and in vitro, in agreement with the analysis of two other yeast pre-mRNAs (24) . Processing a Yeast Mutant RP51A Pre-mRNA in a HeLa Cell Nuclear Extract. rp51A3 is a 48-nt deletion derivative of rp5lAA2, lacking the sequences from 35 to 82 nt upstream from the 3' splice site (ref. 9; Fig. 4 Lower). rpS1A3 is therefore missing both the authentic TACTAAC box and the sequence used as the branch point in the HeLa cell extract. There is no detectable splicing of rp5lAA3 pre-mRNA in yeast cells (9) or in yeast extracts (data not shown). To test whether a HeLa cell extract is capable of processing this mutant pre-mRNA, SP6/rpSlAA3 transcripts were incubated in the HeLa cell nuclear extract and the products were fractionated on a 7% denaturing polyacrylamide gel (Fig. 4) .. cessed in parallel. The SP6/rp5lAA3 pre-mRNA undergoes accurate 5' splice-site cleavage and lariat formation, generating the 77-nt exon 1 and the IVS-exon 2 intermediates, the latter of which comigrates with the pre-mRNA on a 7% denaturing gel. Significantly, accurately spliced RNA (397 nt) and the excised IVS are also detectable (Fig. 4) the HeLa cell splicing factors. However, the yeast TAC-TAAC box is ignored and RNA branch formation occurs at adenosine residues located closer to the 3' splice site. These data are consistent with studies that indicate the major constraint on branch point selection in mammalian cells appears to be distance from the 3' splice site; all the branch points that have been defined to date are 18-37 nt upstream from the 3' splice junction (3, (10) (11) (12) . The TACTAAC box in the yeast rp5lA pre-mRNA is beyond this distance and probably for this reason cannot function as a branch point sequence in the HeLa cell extract. The differences in branch point selection in yeast versus higher eukaryotes and, in particular, the observation that the RNA processing products of the same pre-mRNAs differ in the two systems, suggests that the biochemical factors involved in branch point selection may bear important functional differences. Relevant to this issue are the recent observations that the role of the 3' splice site in the first stage of pre-mRNA splicing, 5' splice-site cleavage and lariat formation, differ in yeast and higher eukaryotes. In higher eukaryotes, at least a portion of the 3' splice-site consensus sequence is necessary for 5' splice-site cleavage and lariat formation (11, 25, 26) . In contrast, 5' splice-site cleavage and lariat formation in yeast pre-mRNAs can occur in the absence of much and perhaps all of the 3' splice-site consensus sequence (27) .
Based on the results in this paper and the related studies discussed above, we suggest that, in yeast, a biochemical factor(s) involved in 5' splice-site cleavage and lariat formation specifically recognizes the TACTAAC box as an early event in splicing; recognition of the 3' splice junction occurs subsequently. In higher eukaryotes, the 3' splice-site consensus sequence rather than the branch point is primarily recognized; the branch point is subsequently (or simultaneously) selected, based in part on distance from the 3' splice site. As previously suggested (12), a factor may recognize the 3' splice-site consensus sequence and the size of this factor provides the distance constraint for branch point selection in higher eukaryotes. The biochemical basis for these mechanistic differences in pre-mRNA splicing between yeast and higher eukaryotes will be fully understood by identifying and characterizing the biochemical components that are involved in the pre-mRNA splicing reactions in both systems. 
